Inotuzumab Ozogamicin Linked to Greater Short-Term Weight Changes in Pediatric Leukemia
A study of pediatric leukemia patients and FAERS data reveals that antibody-drug conjugates are associated with disproportionate nutritional and metabolic ...
A study of pediatric leukemia patients and FAERS data reveals that antibody-drug conjugates are associated with disproportionate nutritional and metabolic ...
A real-world pharmacovigilance analysis of the FDA Adverse Event Reporting System identified 4,326 adverse event reports associated with alglucosidase alfa ...
A disproportionality analysis of the FAERS database evaluated 954 adverse event reports for eculizumab in neuromyelitis optica spectrum disorder, identifying ...
A novel two-dimensional framework integrates FAERS pharmacovigilance reports with Global Burden of Disease estimates to prioritize gynecological cancer drug safety ...
Staff working in larger long-term care facilities across Poland's Mazovian Province perceive a diminished level of patient safety culture compared ...
A single-center study found a large language model exactly matched adjudicated expert severity classifications in 49 percent of 286 hospital ...
A retrospective analysis of Brazil's VigiMed database identified 191 radiopharmaceutical drug entries in 126 adverse event reports, with Xofigo and ...
A FAERS pharmacovigilance study found disproportionate skin-cancer reporting for risankizumab, tildrakizumab and ustekinumab, but the spontaneous-report data do not establish ...
A retrospective FAERS analysis of 321 givinostat reports identified platelet abnormalities and increased blood triglycerides as prominent safety signals but ...
A BMJ study of FDA MAUDE summary reports finds widespread incompleteness, undercounting, misclassification, and missed deadlines in medical device adverse ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine